← 產業報告目錄
Animal Drug Compounding Market Size, Share & Trends Analysis Report By Animal Type (Companion Animals, Livestock Animals), By Product (Anti-infective Agents, Anti-inflammatory Agents, Hormones & Substitutes, CNS Agents, GI Drugs), By Route of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-03頁數 180報告編號 INSIGHTACE-58d3a17553
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Industry analysis indicates the Animal Drug Compounding Market globally will expand at a 8.2% CAGR during 2025–2034.
Animal Drug Compounding covers reshaping how healthcare entities approach this space.
The market's upward path is supported by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Animal Drug Compounding Market Snapshot
Chapter 4. Global Animal Drug Compounding Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Animal Type Estimates & Trend Analysis
5.1. by Animal Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Animal Type:
5.2.1. Companion Animals
5.2.1.1. Dogs
5.2.1.2. Cats
5.2.1.3. Others
5.2.2. Livestock Animals
Chapter 6. Market Segmentation 2: by Products Estimates & Trend Analysis
6.1. by Products & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Products:
6.2.1. Anti-infectives
6.2.1.1. Metranidazole
6.2.1.2. Ketaconazole
6.2.1.3. Others
6.2.2. Anti-inflammatory
6.2.2.1. Prednisolone
6.2.2.2. Tramadol
6.2.2.3. Others
6.2.3. CNS Agents
6.2.3.1. Potassium Bromide
6.2.3.2. Gabapentin
6.2.3.3. Other CNS Agents
6.2.4. GI Drugs
6.2.4.1. Apomorphine
6.2.4.2. Ursodiol
6.2.4.3. Cisapride
6.2.4.4. Other GI Drugs
6.2.5. Others
6.2.5.1. Methimazole
6.2.5.2. Others
Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis
7.1. by Route of Administration & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Route of Administration:
7.2.1. Oral
7.2.2. Injectable
7.2.3. Topical
7.2.4. Others
Chapter 8. Market Segmentation 4: by Form Estimates & Trend Analysis
8.1. by Form & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Form:
8.2.1. Suspensions
8.2.2. Solutions
8.2.3. Capsules
Chapter 9. Animal Drug Compounding Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.1.2. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.1.3. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.1.4. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.1.5. North America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.2.2. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.2.3. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.2.4. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.2.5. Europe Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.3.2. Asia Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.3.3. Asia-Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.3.4. Asia-Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.3.5. Asia Pacific Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.4.2. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.4.3. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.4.4. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.4.5. Latin America Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.5.2. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.5.3. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.5.4. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by Form, 2021-2034
9.5.5. Middle East & Africa Animal Drug Compounding Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Akina Animal Health
10.2.2. Aurora Compounding
10.2.3. Caringbah Compounding Pharmacy
10.2.4. Central Compounding Center South
10.2.5. Chiron Compounding Pharmacy
10.2.6. Custom Med Compounding Pharmacy
10.2.7. Davis Islands Pharmacy and Compounding Lab
10.2.8. Dougherty's Pharmacy
10.2.9. Hoye's Pharmacy
10.2.10. Medisca Inc.
10.2.11. MEDS Canadian Compounding Pharmacy
10.2.12. Millers Pharmacy
10.2.13. Pace Pharmacy
10.2.14. People's Choice Pharmacy
10.2.15. Pharmaca.
10.2.16. Pratt's Compounding Pharmacy
10.2.17. Sixth Avenue Medical Pharmacy
10.2.18. Smith Caldwell Drug Store
10.2.19. Smith's Pharmacy
10.2.20. Specialist Compounding Pharmacy Pte Ltd.
10.2.21. Tache Pharmacy
10.2.22. Triangle Compounding Pharmacy Inc.
10.2.23. Vertisis Custom Pharmacy
10.2.24. Victoria Compounding Pharmacy
10.2.25. Vimian
10.2.26. Wedgewood Pharmacy
10.2.27. Wellness Pharmacy of Cary
10.2.28. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們